-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Molekule Group, Inc. annual/quarterly Deferred Income Tax Expense (Benefit) history and growth rate for Q1 2022.
- Molekule Group, Inc. Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2022 was $92.8K.
- Molekule Group, Inc. annual Deferred Income Tax Expense (Benefit) for 2022 was -$501K, a 56.6% decline from 2021.
Deferred Income Tax Expense (Benefit), Quarterly (USD)